How Would a Ban on Prescriber-Identifying Information Impact Pharmaceutical Marketing?

Publisher： IGI Global_journal

E-ISSN： 2155-6431|1|3|38-52

ISSN： 2155-6423

Source： International Journal of Public and Private Healthcare Management and Economics (IJPPHME), Vol.1, Iss.3, 2011-07, pp. : 38-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Validity of the Prescriber Information in the Danish National Prescription Registry

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 119, Iss. 4, 2016-10 ,pp. : 376-380

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mailed prescriber feedback in addition to a clinical guideline has no impact: a randomised, controlled trial

By Søndergaard Jens   Søndergaard Jens   Søndergaard Jens   Søndergaard Jens  

Scandinavian Journal of Primary Health Care, Vol. 21, Iss. 1, 2003-01 ,pp. : 47-51

Informa Healthcare

Access to resources Recommend Favorite

Marketing pharmaceutical and cosmetic products to the mature market

By Moschis George P.   Bovell Leah  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 7, Iss. 4, 2013-11 ,pp. : 357-373

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Health expenditure efficiency: implications for pharmaceutical marketing

By Hilsenrath Peter  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 5, Iss. 2, 2011-06 ,pp. : 118-134

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Use of Atypical Antipsychotics in Nursing Homes and Pharmaceutical Marketing

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 2, 2015-02 ,pp. : 297-301

John Wiley & Sons Inc

Access to resources Recommend Favorite